Illinois medical marijuana: New qualifying conditions added as program becomes permanent

BySara Tenenbaum WLS logo
Wednesday, July 3, 2019
New qualifying conditions for medical marijuana added as program becomes permanent
The list of qualifying conditions for medical marijuana in the state of Illinois has expanded after the General Assembly passed SB 2023, which also makes the state's medical cannab

CHICAGO (WLS) -- The list of qualifying conditions for medical marijuana in the state of Illinois has expanded after the General Assembly passed SB 2023, which also makes the state's medical cannabis program permanent.

The bill, sponsored by Rep. Bob Morgan (D-Highwood), operates independently of HB 1438, which legalized recreational marijuana in Illinois.

Morgan, who was also the architect of the Medical Marijuana Pilot Program, said the bill is meant to stabilize and make permanent the medical cannabis program in Illinois. By keeping the program separate from recreational marijuana, it ensures that any future legislative changes to the recreational law do not affect medical patients, including in the case that the recreational marijuana law is ever repealed.

RELATED: Illinois Weed Legalization Guide

The bill was sent to Governor JB Pritzker to sign on June 12. Morgan said they're still working to set a firm date, he expects Pritzker will sign SB 2023 sometime in the next month.

The Medical Marijuana Pilot program was approved in 2013, began sales in 2015, and was expanded by then-governor Bruce Rauner in 2018. It is considered one of the most restrictive medical programs in the country and was set to expire in July 2020 until SB 2023 passed.

Along with adding new conditions, SB 2023 gives veterans access to medical marijuana through the Opioid Alternative Pilot Program. The 11 new qualifying conditions for medical marijuana patients are: autism, chronic pain, irritable bowel syndrome, migraines, osteoarthritis, anorexia nervosa, Ehler-Danlos Syndrome, Neuro-Behcet's Autoimmune Disease, neuropathy, polycystic kidney disease and superior canal dehiscence syndrome.

The new conditions will be eligible as soon as the Illinois Department of Public Health writes and publishes new rules. A spokesperson for the IDPH's Division of Medical Cannabis said there is currently no set timeline to write and publish the new rules, though they are working to get them drafted as quickly as possible.

Rep. Morgan said the rule writing and publishing process typically takes about 90 days and is comprised of a period of public comment and then legislative review.

There are 55 medical marijuana dispensaries currently operating in Illinois, and more licenses are expected to be issued in 2020. Medical marijuana patients are also the only people who can cultivate marijuana plants at home under the recreational law. Patients will be able to grow up to five plants, which Morgan said most benefits rural patients who live far away from dispensaries. He said that medical patients will also have first-in-line access to marijuana and marijuana products in case of a supply shortage after recreational use begins next year.

For more information on medical marijuana in Illinois and how to get patient card if you have a qualifying condition, click here.


- Cancer

- Glaucoma

- HIV positive status


- Hepatitis C

- Amyotophic lateral sclerosis

- Crohn's disease (including, but not limited to, ulcerative colitis)

- Agitation of Alzheimer's disease

- Cachexia/wasting syndrome

- Muscular dystrophy

- Severe fibromyalgia

- Spinal cord disease, including but not limited to arachnoiditis

- Tarlov cysts

- Hydromyelia

- Syringomyelia

- Rheumatoid arthritis

- Fibrous dysplasia

- Spinal cord injury

- Traumatic brain injury and post-concussion syndrome

- Multiple Sclerosis

- Arnold-Chiari malformation and Syringomyelia

- Spinocerebellar Ataxia (SCA)

- Parkinson's disease

- Tourette's syndrome

- Myoclonus

- Dystonia

- Reflext Sympathetic Dystrophy

- RSD (Complex Regional Pain Syndrome Type I)

- Causalgia

- CRPS (Complex Regional Pain Syndrome Type II)

- Neurofibromatosis

- Chronic Inflammatory Demyelinating Polyneuropathy

- Sjogren's syndrome

- Lupus

- Interstitial Cystitis

- Myasthenia Gravis

- Hydrocephalus

- Nail-patella syndrome

- Residual limb pain

- Seizures (including those characteristic of epilepsy)

- Post-Traumatic Stress Disorder (PTSD)

- Autism

- Chronic pain

- Irritable bowel syndrome

- Migraines

- Osteoarthritis

- Anorexia nervosa

- Ehler-Danlos Syndrome

- Neuro-Behcet's Autoimmune Disease

- Polycystic kidney disease

- Neuropathy

- Superior canal dehiscence syndrome

- Terminal illness with a diagnosis of six months or less, if the illness is not already a qualifying debilitating medical condition